EFXT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Enerflex Ltd (EFXT) presents a strong long-term investment opportunity for a beginner investor with $50,000-$100,000 available for investment. The company's recent financial performance, including improved revenue, record free cash flow, and reduced net debt, coupled with the positive momentum in its stock price, makes it a compelling buy. While the RSI indicates overbought conditions, the bullish moving averages and positive MACD suggest continued upward momentum. The recent downgrade by Raymond James reflects profit-taking after a strong rally but still acknowledges potential near-term catalysts and reasonable valuation. The absence of significant insider or hedge fund activity and no recent congress trading data further supports a stable investment environment.
The stock is currently in a bullish trend, with the MACD histogram at 0.255 (positively expanding), RSI at 91.067 (overbought), and moving averages aligned bullishly (SMA_5 > SMA_20 > SMA_200). Key resistance levels are at R1: 22.487 and R2: 23.86, with the stock closing above R2, indicating strong upward momentum.
Q4 2025 revenue increased by 11.8% YoY, surpassing expectations.
Record free cash flow of $141 million and improved operational efficiency.
Net debt reduced to $501 million, with a net debt-to-EBITDA ratio of 1.0x.
Agreement to divest Asia-Pacific operations to focus on core business.
Positive MACD and bullish moving averages.
RSI indicates overbought conditions, suggesting potential short-term pullback.
Net income and EPS declined significantly YoY in Q4
Recent downgrade by Raymond James from Strong Buy to Outperform due to profit-taking after a strong rally.
In Q4 2025, Enerflex achieved $627 million in revenue (+11.8% YoY), record free cash flow of $141 million, and a net debt-to-EBITDA ratio of 1.0x. However, net income dropped to -$57 million (-480% YoY), and EPS fell to -$0.47 (-491.67% YoY). Gross margin decreased to 22.81%, down 8.61% YoY.
Raymond James downgraded the stock to Outperform from Strong Buy with a C$26 price target, citing profit-taking after a +30% rally in under two months. The firm still sees reasonable valuation and potential near-term catalysts, but the stock is no longer in 'pound the table' territory.
